Navigation Links
New Chemistry Approach Promises Less Expensive Drugs

With a newly discovered method of assembling organic molecules, a team of Princeton University chemists may have found a way to sidestep many of the expensive// and hazardous barriers that stand in the way of drug development.

The new approach allows scientists to synthesize molecules without employing toxic catalysts, and it also does not generate alternate versions of drug molecules that can damage the body, two perennial issues that plague the manufacturing process. David MacMillan, one of the researchers on the team, said the discovery is important not only for its industrial applications, but also because of the new research possibilities it opens up.

"This is a new type of chemistry that could expand the way people think about making biologically active molecules," said MacMillan, who holds Princeton's A. Barton Hepburn Chair of Chemistry and directs the chemistry department's Merck Center for Catalysis. "We've found more than a new chemical reaction. It's a common mode of molecule activation that allows a whole group of reactions to take place."

Broadly stated, the discovery will open up new possibilities for working with ketones and aldehydes, two chemical groups that are found on a large percentage of the substances in which organic chemists are interested. "They form a big region of the reaction landscape," MacMillan said.

The paper, which MacMillan cowrote with first author Teresa Beeson, Anthony Mastracchio, Jun-Bae Hong and Kate Ashton, all members of his research group, appears in the March 29 issue of the journal Science. John Schwab, a chemist at the National Institutes of Health (NIH), applauded the work for the new possibilities it could provide.

"One sometimes hears that organic chemistry is a mature field, but MacMillan's work shows that there still are rich veins waiting to be mined," said Schwab, also a program director at the NIH's National Institute of General Medical Sciences, which
'"/>




Page: 1 2 3 4

Related medicine news :

1. Love And Drug Addiction Share The Same Chemistry
2. The Chemistry Of Sexual Attraction Between Male And Female Elephants
3. Chemistry Over The Counter: Is It Just What The Doctor Ordered?
4. New Dietary Approach To Manage Kidney Stones
5. Approaching through Telemedicine benefits patients
6. Gel Offers A More Targeted Approach
7. New Cost Effective Approach To Promote Sun Protection
8. Treatment Of Brain Aneurysms By A New Non-Surgical Approach
9. A New Approach In Treatment Neurogenic Detrusor Overactivity In Children
10. A New Diagnostic Approach To Pediatric Interstitial Lung Disease
11. Lazy Eye Can Be Effectively Treated By New Approach

Post Your Comments:
(Date:12/4/2009)...itate to take breast cancer drug, study finds , ...es about side effects are a major reason why only ...t cancer are willing to take the drug tamoxifen to...n effort to inform women about the risks and benef... Michigan Comprehensive Cancer Center created a de...
(Date:12/4/2009)...ntor Showcasing Innovative Health Product in Scott...4, 2009 -- A valley inventor garnering national at...ls lose weight, prevent disease, restore health, i...ing the product at Saturday’s Technology Fai...rekDesk has been featured on major television net...
(Date:12/4/2009)...Dec. 4 Today, seven of Florida,s t...proving the health of Florida,s uninsured and unde...da,s 2009 Sapphire Award ceremony. ,, The Sapph...ecognizes and promotes organizations that have dem...ies within their communities. ,, Honorees of Th...
(Date:12/4/2009)...wire-USNewswire/ -- As Congress prepares to vote o...ncil (FRC) today announced an eight week campaign ...y each household on provisions of the Senate healt...oning, higher taxes, and government-run health car...express opposition to the so-called health care re...
(Date:12/4/2009)...ewswire-FirstCall/ -- Movado Group Inc. (NYSE: M...tlanta, Georgia, shared in a tribute on December 3...Melanie Oudin for her stellar performance in the t...arterfinalist at the Open since 1999. ,, (Phot...NY21184 ) ,, At a celebratory reception held at...
Breaking Medicine News(10 mins):Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Valley Health Invention Making National Splash Showcased at Scottsdale Civic Center Gallery 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3Health News:FRC Announces Campaign to Call Every Louisiana Household, Urging Opposition to Health Care Takeover 2
...pies found medications cut withdrawal, urge to dri... Sticking to a regimen of prescribed medications i...toms and urges to drink alcohol in those being tre...o behavioral treatments -- low-intensity medical m...
...ric, an Asian spice found in many curries, has a l...ng wounds and relieving pain, but can it prevent d...ny diseases and is believed to be involved in onse...ia University Medical Center, and his colleagues w...
...ves head in fundraising challenge, MILLERSVILLE, ...tionwide leader in wholesale vacation accommodatio... for juvenile alopecia,areata, an autoimmune disor...,promised to shave his head if TAN employees reach...
... candlelight ceremony in Newark, NEWARK, N.J., Ju...ogether Saturday night to celebrate cancer survivo...he disease at an overnight event,in Newark., Team...The event is held overnight to represent the fact ...
... having both a sexually transmitted disease (STD) ...uring early pregnancy were four times more likely ...fect in which infants are born with their intestin...he researchers caution must be verified with furth...
...a threefold increased risk of disease, report says...heumatoid arthritis (RA) patients treated with met...and other cancers, an Australian study says. , Me...ggested, and there are even concerns that the drug...
Other Medicine News:Health News:Prescribed Meds Still Best Treatment for Alcoholism 2Health News:Common cooking spice shows promise in combating diabetes and obesity 2Health News:TAN Employees Shave the Way for the Fight Against Alopecia 2Health News:Sexually transmitted disease, urinary tract infections may be bad combination for birth defect 2Health News:Sexually transmitted disease, urinary tract infections may be bad combination for birth defect 3Health News:Rheumatoid Arthritis Drug Boosts Melanoma Incidence 2
(Date:12/4/2009)...OREST, Ill., Dec. 4 Hosp...ty pharmaceutical and medication delivery company,... 50 mL and 100 mL VisIV(TM) containers for intrave...ers a complete size range (50 mL to 1 L) of the aw...duct. The launch of the 50 mL and 100 mL container...
(Date:12/4/2009)... Dec. 4 Axsun Technologi...poration (Nasdaq: VOLC ), today announced the ini... integrated light source architecture for OCT imag...ne design raises the bar on imaging speed and over...ns for swept source OCT light sources. This appro...
(Date:12/4/2009)... Drs. Neal Shore and E. David Craw...en (PSA) recurrence from the additional analysis o...ate in a Phase III pivotal study of FIRMAGON®...rolide in prostate cancer patients during the firs... received FIRMAGON 240/80 mg/month had a recurrenc...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 1Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 2Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 3Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 4Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 5New York Citys World Product Centre Announces Initial Charter Partners 50551 1New York Citys World Product Centre Announces Initial Charter Partners 50551 2New York Citys World Product Centre Announces Initial Charter Partners 50551 3New York Citys World Product Centre Announces Initial Charter Partners 50551 4Celiac Disease Making Inroads in U S 50549 1Celiac Disease Making Inroads in U S 50549 2
...doption of Safe, Non-Drug Option to Lower Blood Pr...NEW YORK, Jan. 24 InterCure, Ltd. (Tel Aviv Stock...hypertension treatment,device, clinically-proven t...ced it sold its 100,000th RESPeRATE device during ...riod of widespread consumer adoption and,physician...
...cribing behavior appear inconsistent with ACC stat...sults, MOUNT LAUREL, N.J., Jan. 24 ImpactRx, Inc... pharmaceutical promotion on,physicians, prescribi...p in,prescribing Zetia and Vytorin since Merck / S...lts on January 14. That study was designed to,dete...
Other Medicine Technology:InterCure Announces 100,000th RESPeRATE Unit Sold 2InterCure Announces 100,000th RESPeRATE Unit Sold 3ImpactRx Tracks Decline in Zetia and Vytorin Prescribing 2ImpactRx Tracks Decline in Zetia and Vytorin Prescribing 3
Goat Anti-Human IgA, alpha chain Antibody, Colloidal Gold Conjugated, 50 OD
Protein A 50 OD, Colloidal Gold Conjugated/Tagged
Protein A, Gold Ribbon - .25 OD per sq. cm.
Protein G, Gold Ribbon - .50 OD per sq. cm.
Medicine Products: